ZYVERSA THERAPEUTICS, INC. Debt Instrument, Interest Rate, Effective Percentage
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Debt Instrument, Interest Rate, Effective Percentage of 2.00% as of 2023-02-20, per its 10-K filed 2024-03-25.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateEffectivePercentage · last filed 2024-03-25
- 2023-02-20: Debt Instrument, Interest Rate, Effective Percentage 2.00%.
| Period end | Debt Instrument, Interest Rate, Effective Percentage |
|---|---|
| 2023-02-20 | 2.00% 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |